BEAT BioTherapeutics Corp.

1380-112th Avenue NE Suite 200
Bellevue, WA 98004
Click for website

Research Sector Biotechnology

Summary Description Therapies for heart disease, based on a fundamental discovery in cardiac muscle contraction

Management Michael Kranda, CEO; Gregory G, Mahairas, Ph.D.

Click here for Financial Data
Keywords: Heart Disease, Cardiac Failure, Gene Therapy, heart, cardiology, cardio, datp


Updated: Dec. 08, 2015


BEAT BioTherapeutics Corp. (BEATBio) is a biotechnology company founded to develop novel therapies for heart disease. BEAT Bios first product is based on a fundamental discovery in cardiac muscle co......view more

Technology / Differentiation

The founders discovery employs a novel biological agent for therapeutic use by raising the production of DeoxyAdenosine Triphosphate (dATP) in the metabolic synthesis of ATP. Essentially, the hearts...view more

Market / Customers

26 million people worldwide survive after suffering from heart failure. The market for heart disease therapeutics was $3 B in 2005 and grew at a Compound Annual Growth Rate of 4.5% to reach $4.1 B in ......view more

Revenue / Funding

Funding to date - $3M; Financing sought Series A preferred equity, up to $18M...view more


Cooley LLP...view more